Login / Signup

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer.

Manuel AbreuPablo Cabezas-SainzLorena Alonso-AlconadaAlba FerreirósPatricia Mondelo-MacíaRamón Manuel Lago-LestónAlicia AbaloEva DíazSara Palacios-ZambranoAlejandro Rojo-SebastianRafael LópezLaura SánchezGema Moreno-BuenoLaura Muinelo-Romay
Published in: Cells (2020)
Overall, we evidenced the utility of the molecular characterization of EpCAM+ CTCs from advanced ovarian cancer patients to identify biomarkers with potential applicability for disseminated disease detection and as therapeutic targets such as TIMP1.
Keyphrases
  • circulating tumor cells
  • circulating tumor
  • human health
  • single cell
  • risk assessment
  • climate change
  • label free
  • real time pcr